Allstate plans sale of 32,996 common shares

An affiliate of Allstate filed notice of a proposed sale of up to 32,996 shares of Allstate common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $8,886,803.34 as of August 7, 2026.

Rhea-AI Filing Summary

An affiliate of Allstate filed notice of a proposed sale of up to 32,996 shares of Allstate common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $8,886,803.34 as of August 7, 2026. The filing lists 252,857,950 Allstate common shares outstanding as context. The shares to be sold were previously acquired through restricted stock vesting awards, including 26,834 shares vested on April 4, 2020, 5,295 shares vested on February 17, 2025, and 867 shares vested on February 21, 2025, all categorized as compensation.

Key Figures

Shares proposed for sale: 32,996 shares Aggregate market value of proposed sale: $8,886,803.34 Common shares outstanding: 252,857,950 shares +4 more

7 metrics

Shares proposed for sale 32,996 shares Allstate common stock listed for potential sale via Fidelity on NYSE

Aggregate market value of proposed sale $8,886,803.34 Value associated with 32,996 Allstate common shares

Common shares outstanding 252,857,950 shares Allstate common shares outstanding as referenced in the notice

Restricted stock vesting 04/04/2020 26,834 shares Allstate restricted stock vested as compensation on April 4, 2020

Restricted stock vesting 02/17/2025 5,295 shares Allstate restricted stock vested as compensation on February 17, 2025

Restricted stock vesting 02/21/2025 867 shares Allstate restricted stock vested as compensation on February 21, 2025

Proposed sale date reference 08/07/2026 Date associated with the proposed sale of Allstate common stock

Key Terms

Form 144, Restricted Stock Vesting, Compensation

3 terms

Form 144 regulatory

"144: Securities Information Common | Fidelity Brokerage Services LLC"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 04/04/2020 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"04/04/2020 | Compensation Common | 02/17/2025 | Restricted Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for ALL in this Form 144?

The filing discloses a proposed sale of up to 32,996 shares of Allstate common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $8,886,803.34 as of August 7, 2026.

What is the aggregate market value of Allstate (ALL) shares covered by this Form 144?

The proposed sale covers Allstate common stock with an aggregate market value of $8,886,803.34. This value is tied to the 32,996 shares indicated in the notice for potential sale on the NYSE.

How many Allstate (ALL) common shares are outstanding according to this filing?

The filing lists 252,857,950 Allstate common shares outstanding. This figure provides context for the proposed sale of 32,996 shares and reflects the size of the company’s common equity base at the time referenced.

How were the Allstate (ALL) shares to be sold originally acquired?

The shares to be sold were acquired through restricted stock vesting as compensation, including 26,834 shares vested on April 4, 2020, 5,295 shares on February 17, 2025, and 867 shares on February 21, 2025.

Which broker is handling the proposed Allstate (ALL) share sale?

The proposed sale of Allstate common stock is listed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The shares are noted as being tradable on the NYSE exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 03:48 PM Accepted by SEC EDGAR 08/07/2026 - 03:47 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001699842
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALLSTATE CORP
SEC File Number	001-11840
Address of Issuer	3100 SANDERS ROAD NORTHBROOK ILLINOIS 60062
Phone	8474025000
Name of Person for Whose Account the Securities are To Be Sold	Dugenske John E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	32996	8886803.34	252857950	08/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/04/2020	Restricted Stock Vesting	Issuer			26834	04/04/2020	Compensation
Common	02/17/2025	Restricted Stock Vesting	Issuer			5295	02/17/2025	Compensation
Common	02/21/2025	Restricted Stock Vesting	Issuer			867	02/21/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for John Dugenske
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)